Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NHGRI

Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers

  • Read more about Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers
Japan
2000-578492
Filed on 1999-10-28

Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers

  • Read more about Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers
European Patent
99971049.4
Filed on 1999-10-28

METHOD FOR SIMULTANEOUS DETECTION OF MULTIPLE FLUOROPHORES FOR IN SITU HYBRIDIZATION

  • Read more about METHOD FOR SIMULTANEOUS DETECTION OF MULTIPLE FLUOROPHORES FOR IN SITU HYBRIDIZATION
Patent Cooperation Treaty
PCT/US97/006225
Filed on 1997-04-16

Ataxia Telangiectasia Gene

  • Read more about Ataxia Telangiectasia Gene
Patent Cooperation Treaty
PCT/US96/07040
Filed on 1996-05-16

TUMOR TISSUE MICROARRAYS FOR RAPID MOLECULAR PROFILING

  • Read more about TUMOR TISSUE MICROARRAYS FOR RAPID MOLECULAR PROFILING
US Application 10/215,762
Filed on 2002-08-09

Specific Inhibition of Gene Expression By Small Double Strands RNAS

  • Read more about Specific Inhibition of Gene Expression By Small Double Strands RNAS
Patent Cooperation Treaty
PCT/US02/24226
Filed on 2002-07-30

SELECTIONS OF GENES AND METHODS OF USING THE SAME FOR DIAGNOSIS AND FOR TARGETING THE THERAPY OF SELECT CANCERS

  • Read more about SELECTIONS OF GENES AND METHODS OF USING THE SAME FOR DIAGNOSIS AND FOR TARGETING THE THERAPY OF SELECT CANCERS
US Patent 7,655,397
Filed on 2002-05-31

HIGH-THROUGHPUT TISSUE MICROARRAY TECHNOLOGY AND APPLICATIONS

  • Read more about HIGH-THROUGHPUT TISSUE MICROARRAY TECHNOLOGY AND APPLICATIONS
US Application 10/149,520
Filed on 2003-04-14

Signal Counting For In SITU Hybridization

  • Read more about Signal Counting For In SITU Hybridization
US Application 10/088,269
Filed on 2002-03-15

Use of Interferon-inducible 2',5'-Oligoadenylate-dependent RNase L in The Diagnosis, Prognosis And Treatment of Cancer

  • Read more about Use of Interferon-inducible 2',5'-Oligoadenylate-dependent RNase L in The Diagnosis, Prognosis And Treatment of Cancer
Patent Cooperation Treaty
PCT/US02/19516
Filed on 2002-06-20

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 59
  • Page 60
  • Page 61
  • Page 62
  • Page 63
  • Page 64
  • Page 65
  • Page 66
  • Page 67
  • …
  • Next page ››
  • Last page Last »
Subscribe to NHGRI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health